ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL — Stella

View on ClinicalTrials.gov

Recruiting

Back to Lymphoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Columbia University, New York, New York

Key details

Sponsor

Hua-Jay J Cherng, MD

Collaborators

National Cancer Institute (NCI), Conquer Cancer Foundation

Enrollment target

~40 participants

Started

December 2024

Primary completion

December 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.